The global Multi-Infarct Dementia market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Multi-cerebral infarction dementia is a series of small strokes that cause disruption of blood flow to the brain. It is the highest incidence among people over 65 years of age.
This report aims to provide a comprehensive presentation of the global market for Multi-Infarct Dementia, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Multi-Infarct Dementia. This report contains market size and forecasts of Multi-Infarct Dementia in global, including the following market information:
- Global Multi-Infarct Dementia Market Revenue, 2018-2023, 2024-2030, ($ millions)
- Global top five companies in 2022 (%)
The increase in the global elderly population has also contributed to the development of the global market for multi-infarct dementia.
We surveyed the Multi-Infarct Dementia companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Multi-Infarct Dementia Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Multi-Infarct Dementia Market Segment Percentages, by Type, 2022 (%)
- Pharmacological Treatment
- Non Pharmacological Treatment
Global Multi-Infarct Dementia Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Multi-Infarct Dementia Market Segment Percentages, by Application, 2022 (%)
Global Multi-Infarct Dementia Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Multi-Infarct Dementia Market Segment Percentages, By Region and Country, 2022 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Multi-Infarct Dementia revenues in global market, 2018-2023 (estimated), ($ millions)
- Key companies Multi-Infarct Dementia revenues share in global market, 2022 (%)
Key players include:
- Forest Laboratories
- Janssen Pharmaceuticals
- Novartis Pharmaceutical
- Pfizer
- Eisai
- Ortho-McNeil Pharmaceutical
- Takeda
- Jubilant Cadista Pharmaceuticals
- Takeda Pharmaceutical
Outline of Major Chapters:
Chapter 1: Introduces the definition of Multi-Infarct Dementia, market overview.
Chapter 2: Global Multi-Infarct Dementia market size in revenue.
Chapter 3: Detailed analysis of Multi-Infarct Dementia company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Multi-Infarct Dementia in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Multi-Infarct Dementia Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Multi-Infarct Dementia Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Multi-Infarct Dementia Overall Market Size
2.1 Global Multi-Infarct Dementia Market Size: 2022 VS 2030
2.2 Global Multi-Infarct Dementia Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Multi-Infarct Dementia Players in Global Market
3.2 Top Global Multi-Infarct Dementia Companies Ranked by Revenue
3.3 Global Multi-Infarct Dementia Revenue by Companies
3.4 Top 3 and Top 5 Multi-Infarct Dementia Companies in Global Market, by Revenue in 2022
3.5 Global Companies Multi-Infarct Dementia Product Type
3.6 Tier 1, Tier 2 and Tier 3 Multi-Infarct Dementia Players in Global Market
3.6.1 List of Global Tier 1 Multi-Infarct Dementia Companies
3.6.2 List of Global Tier 2 and Tier 3 Multi-Infarct Dementia Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Multi-Infarct Dementia Market Size Markets, 2022 & 2030
4.1.2 Pharmacological Treatment
4.1.3 Non Pharmacological Treatment
4.2 By Type - Global Multi-Infarct Dementia Revenue & Forecasts
4.2.1 By Type - Global Multi-Infarct Dementia Revenue, 2018-2023
4.2.2 By Type - Global Multi-Infarct Dementia Revenue, 2024-2030
4.2.3 By Type - Global Multi-Infarct Dementia Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Multi-Infarct Dementia Market Size, 2022 & 2030
5.1.2 Academic
5.1.3 Hospitals
5.1.4 Other
5.2 By Application - Global Multi-Infarct Dementia Revenue & Forecasts
5.2.1 By Application - Global Multi-Infarct Dementia Revenue, 2018-2023
5.2.2 By Application - Global Multi-Infarct Dementia Revenue, 2024-2030
5.2.3 By Application - Global Multi-Infarct Dementia Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Multi-Infarct Dementia Market Size, 2022 & 2030
6.2 By Region - Global Multi-Infarct Dementia Revenue & Forecasts
6.2.1 By Region - Global Multi-Infarct Dementia Revenue, 2018-2023
6.2.2 By Region - Global Multi-Infarct Dementia Revenue, 2024-2030
6.2.3 By Region - Global Multi-Infarct Dementia Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Multi-Infarct Dementia Revenue, 2018-2030
6.3.2 US Multi-Infarct Dementia Market Size, 2018-2030
6.3.3 Canada Multi-Infarct Dementia Market Size, 2018-2030
6.3.4 Mexico Multi-Infarct Dementia Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Multi-Infarct Dementia Revenue, 2018-2030
6.4.2 Germany Multi-Infarct Dementia Market Size, 2018-2030
6.4.3 France Multi-Infarct Dementia Market Size, 2018-2030
6.4.4 U.K. Multi-Infarct Dementia Market Size, 2018-2030
6.4.5 Italy Multi-Infarct Dementia Market Size, 2018-2030
6.4.6 Russia Multi-Infarct Dementia Market Size, 2018-2030
6.4.7 Nordic Countries Multi-Infarct Dementia Market Size, 2018-2030
6.4.8 Benelux Multi-Infarct Dementia Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Multi-Infarct Dementia Revenue, 2018-2030
6.5.2 China Multi-Infarct Dementia Market Size, 2018-2030
6.5.3 Japan Multi-Infarct Dementia Market Size, 2018-2030
6.5.4 South Korea Multi-Infarct Dementia Market Size, 2018-2030
6.5.5 Southeast Asia Multi-Infarct Dementia Market Size, 2018-2030
6.5.6 India Multi-Infarct Dementia Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Multi-Infarct Dementia Revenue, 2018-2030
6.6.2 Brazil Multi-Infarct Dementia Market Size, 2018-2030
6.6.3 Argentina Multi-Infarct Dementia Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Multi-Infarct Dementia Revenue, 2018-2030
6.7.2 Turkey Multi-Infarct Dementia Market Size, 2018-2030
6.7.3 Israel Multi-Infarct Dementia Market Size, 2018-2030
6.7.4 Saudi Arabia Multi-Infarct Dementia Market Size, 2018-2030
6.7.5 UAE Multi-Infarct Dementia Market Size, 2018-2030
7 Multi-Infarct Dementia Companies Profiles
7.1 Forest Laboratories
7.1.1 Forest Laboratories Company Summary
7.1.2 Forest Laboratories Business Overview
7.1.3 Forest Laboratories Multi-Infarct Dementia Major Product Offerings
7.1.4 Forest Laboratories Multi-Infarct Dementia Revenue in Global Market (2018-2023)
7.1.5 Forest Laboratories Key News & Latest Developments
7.2 Janssen Pharmaceuticals
7.2.1 Janssen Pharmaceuticals Company Summary
7.2.2 Janssen Pharmaceuticals Business Overview
7.2.3 Janssen Pharmaceuticals Multi-Infarct Dementia Major Product Offerings
7.2.4 Janssen Pharmaceuticals Multi-Infarct Dementia Revenue in Global Market (2018-2023)
7.2.5 Janssen Pharmaceuticals Key News & Latest Developments
7.3 Novartis Pharmaceutical
7.3.1 Novartis Pharmaceutical Company Summary
7.3.2 Novartis Pharmaceutical Business Overview
7.3.3 Novartis Pharmaceutical Multi-Infarct Dementia Major Product Offerings
7.3.4 Novartis Pharmaceutical Multi-Infarct Dementia Revenue in Global Market (2018-2023)
7.3.5 Novartis Pharmaceutical Key News & Latest Developments
7.4 Pfizer
7.4.1 Pfizer Company Summary
7.4.2 Pfizer Business Overview
7.4.3 Pfizer Multi-Infarct Dementia Major Product Offerings
7.4.4 Pfizer Multi-Infarct Dementia Revenue in Global Market (2018-2023)
7.4.5 Pfizer Key News & Latest Developments
7.5 Eisai
7.5.1 Eisai Company Summary
7.5.2 Eisai Business Overview
7.5.3 Eisai Multi-Infarct Dementia Major Product Offerings
7.5.4 Eisai Multi-Infarct Dementia Revenue in Global Market (2018-2023)
7.5.5 Eisai Key News & Latest Developments
7.6 Ortho-McNeil Pharmaceutical
7.6.1 Ortho-McNeil Pharmaceutical Company Summary
7.6.2 Ortho-McNeil Pharmaceutical Business Overview
7.6.3 Ortho-McNeil Pharmaceutical Multi-Infarct Dementia Major Product Offerings
7.6.4 Ortho-McNeil Pharmaceutical Multi-Infarct Dementia Revenue in Global Market (2018-2023)
7.6.5 Ortho-McNeil Pharmaceutical Key News & Latest Developments
7.7 Takeda
7.7.1 Takeda Company Summary
7.7.2 Takeda Business Overview
7.7.3 Takeda Multi-Infarct Dementia Major Product Offerings
7.7.4 Takeda Multi-Infarct Dementia Revenue in Global Market (2018-2023)
7.7.5 Takeda Key News & Latest Developments
7.8 Jubilant Cadista Pharmaceuticals
7.8.1 Jubilant Cadista Pharmaceuticals Company Summary
7.8.2 Jubilant Cadista Pharmaceuticals Business Overview
7.8.3 Jubilant Cadista Pharmaceuticals Multi-Infarct Dementia Major Product Offerings
7.8.4 Jubilant Cadista Pharmaceuticals Multi-Infarct Dementia Revenue in Global Market (2018-2023)
7.8.5 Jubilant Cadista Pharmaceuticals Key News & Latest Developments
7.9 Takeda Pharmaceutical
7.9.1 Takeda Pharmaceutical Company Summary
7.9.2 Takeda Pharmaceutical Business Overview
7.9.3 Takeda Pharmaceutical Multi-Infarct Dementia Major Product Offerings
7.9.4 Takeda Pharmaceutical Multi-Infarct Dementia Revenue in Global Market (2018-2023)
7.9.5 Takeda Pharmaceutical Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Multi-Infarct Dementia Market Opportunities & Trends in Global Market
Table 2. Multi-Infarct Dementia Market Drivers in Global Market
Table 3. Multi-Infarct Dementia Market Restraints in Global Market
Table 4. Key Players of Multi-Infarct Dementia in Global Market
Table 5. Top Multi-Infarct Dementia Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Multi-Infarct Dementia Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Multi-Infarct Dementia Revenue Share by Companies, 2018-2023
Table 8. Global Companies Multi-Infarct Dementia Product Type
Table 9. List of Global Tier 1 Multi-Infarct Dementia Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Multi-Infarct Dementia Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Multi-Infarct Dementia Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Multi-Infarct Dementia Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Multi-Infarct Dementia Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Multi-Infarct Dementia Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Multi-Infarct Dementia Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Multi-Infarct Dementia Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Multi-Infarct Dementia Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Multi-Infarct Dementia Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Multi-Infarct Dementia Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Multi-Infarct Dementia Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Multi-Infarct Dementia Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Multi-Infarct Dementia Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Multi-Infarct Dementia Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Multi-Infarct Dementia Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Multi-Infarct Dementia Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Multi-Infarct Dementia Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Multi-Infarct Dementia Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Multi-Infarct Dementia Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Multi-Infarct Dementia Revenue, (US$, Mn), 2024-2030
Table 30. Forest Laboratories Company Summary
Table 31. Forest Laboratories Multi-Infarct Dementia Product Offerings
Table 32. Forest Laboratories Multi-Infarct Dementia Revenue (US$, Mn) & (2018-2023)
Table 33. Forest Laboratories Key News & Latest Developments
Table 34. Janssen Pharmaceuticals Company Summary
Table 35. Janssen Pharmaceuticals Multi-Infarct Dementia Product Offerings
Table 36. Janssen Pharmaceuticals Multi-Infarct Dementia Revenue (US$, Mn) & (2018-2023)
Table 37. Janssen Pharmaceuticals Key News & Latest Developments
Table 38. Novartis Pharmaceutical Company Summary
Table 39. Novartis Pharmaceutical Multi-Infarct Dementia Product Offerings
Table 40. Novartis Pharmaceutical Multi-Infarct Dementia Revenue (US$, Mn) & (2018-2023)
Table 41. Novartis Pharmaceutical Key News & Latest Developments
Table 42. Pfizer Company Summary
Table 43. Pfizer Multi-Infarct Dementia Product Offerings
Table 44. Pfizer Multi-Infarct Dementia Revenue (US$, Mn) & (2018-2023)
Table 45. Pfizer Key News & Latest Developments
Table 46. Eisai Company Summary
Table 47. Eisai Multi-Infarct Dementia Product Offerings
Table 48. Eisai Multi-Infarct Dementia Revenue (US$, Mn) & (2018-2023)
Table 49. Eisai Key News & Latest Developments
Table 50. Ortho-McNeil Pharmaceutical Company Summary
Table 51. Ortho-McNeil Pharmaceutical Multi-Infarct Dementia Product Offerings
Table 52. Ortho-McNeil Pharmaceutical Multi-Infarct Dementia Revenue (US$, Mn) & (2018-2023)
Table 53. Ortho-McNeil Pharmaceutical Key News & Latest Developments
Table 54. Takeda Company Summary
Table 55. Takeda Multi-Infarct Dementia Product Offerings
Table 56. Takeda Multi-Infarct Dementia Revenue (US$, Mn) & (2018-2023)
Table 57. Takeda Key News & Latest Developments
Table 58. Jubilant Cadista Pharmaceuticals Company Summary
Table 59. Jubilant Cadista Pharmaceuticals Multi-Infarct Dementia Product Offerings
Table 60. Jubilant Cadista Pharmaceuticals Multi-Infarct Dementia Revenue (US$, Mn) & (2018-2023)
Table 61. Jubilant Cadista Pharmaceuticals Key News & Latest Developments
Table 62. Takeda Pharmaceutical Company Summary
Table 63. Takeda Pharmaceutical Multi-Infarct Dementia Product Offerings
Table 64. Takeda Pharmaceutical Multi-Infarct Dementia Revenue (US$, Mn) & (2018-2023)
Table 65. Takeda Pharmaceutical Key News & Latest Developments
List of Figures
Figure 1. Multi-Infarct Dementia Segment by Type in 2022
Figure 2. Multi-Infarct Dementia Segment by Application in 2022
Figure 3. Global Multi-Infarct Dementia Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Multi-Infarct Dementia Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Multi-Infarct Dementia Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Multi-Infarct Dementia Revenue in 2022
Figure 8. By Type - Global Multi-Infarct Dementia Revenue Market Share, 2018-2030
Figure 9. By Application - Global Multi-Infarct Dementia Revenue Market Share, 2018-2030
Figure 10. By Type - Global Multi-Infarct Dementia Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Multi-Infarct Dementia Revenue Market Share, 2018-2030
Figure 12. By Application - Global Multi-Infarct Dementia Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Multi-Infarct Dementia Revenue Market Share, 2018-2030
Figure 14. By Region - Global Multi-Infarct Dementia Revenue Market Share, 2018-2030
Figure 15. By Country - North America Multi-Infarct Dementia Revenue Market Share, 2018-2030
Figure 16. US Multi-Infarct Dementia Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Multi-Infarct Dementia Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Multi-Infarct Dementia Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Multi-Infarct Dementia Revenue Market Share, 2018-2030
Figure 20. Germany Multi-Infarct Dementia Revenue, (US$, Mn), 2018-2030
Figure 21. France Multi-Infarct Dementia Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Multi-Infarct Dementia Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Multi-Infarct Dementia Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Multi-Infarct Dementia Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Multi-Infarct Dementia Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Multi-Infarct Dementia Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Multi-Infarct Dementia Revenue Market Share, 2018-2030
Figure 28. China Multi-Infarct Dementia Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Multi-Infarct Dementia Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Multi-Infarct Dementia Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Multi-Infarct Dementia Revenue, (US$, Mn), 2018-2030
Figure 32. India Multi-Infarct Dementia Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Multi-Infarct Dementia Revenue Market Share, 2018-2030
Figure 34. Brazil Multi-Infarct Dementia Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Multi-Infarct Dementia Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Multi-Infarct Dementia Revenue Market Share, 2018-2030
Figure 37. Turkey Multi-Infarct Dementia Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Multi-Infarct Dementia Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Multi-Infarct Dementia Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Multi-Infarct Dementia Revenue, (US$, Mn), 2018-2030
Figure 41. Forest Laboratories Multi-Infarct Dementia Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Janssen Pharmaceuticals Multi-Infarct Dementia Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Novartis Pharmaceutical Multi-Infarct Dementia Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Pfizer Multi-Infarct Dementia Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Eisai Multi-Infarct Dementia Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Ortho-McNeil Pharmaceutical Multi-Infarct Dementia Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Takeda Multi-Infarct Dementia Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Jubilant Cadista Pharmaceuticals Multi-Infarct Dementia Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Takeda Pharmaceutical Multi-Infarct Dementia Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
